Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Neoplasms 2Skin Neoplasms 1Sezary Syndrome 1Sarcoma, Kaposi 1Neuroectodermal Tumors 1Neoplasms, Neuroepithelial 1Neoplasms, Nerve Tissue 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Breast Neoplasms 1AIDS-related Kaposi sarcoma 1

Interventions

repotrectinib 1pralsetinib 1pamiparib 1Vincristine 1Temozolomide 1Radiotherapy 1Radiation 1Maintenance Chemotherapy 1Lomustine 1Interleukin-12 1Cisplatin 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Neuroectodermal Tumors × Interleukin-12 × Clear all
NCT04388033 2020-06-09

Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1/2 Unknown
10 enrolled
CNS

Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Neoplasms, Neuroepithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡